The clinical spectrum of FTD associated with GRN mutations includes the behavioural variant (bvFTD), primary progressive aphasia (PPA), and dementia associated with movement disorders such as parkinsonism including corticobasal syndrome. This evidence concerns the gene GRN and primary progressive aphasia.